免責聲明
本網站僅提供窩客幫資訊參考平台, 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料(以下簡稱『內容』)。無論其為公開張貼或私下傳送,若有不實或違法情事,均為『內容』提供者之責任,窩客幫概不負責也不承擔任何法律責任。
豐華生物科技股份有限公司
文章管理
Expanding Production, Glac Biotech Leads the Way in Probiotics Industry
The era of post-pandemic wellness is upon us, and the global health product market is rapidly expanding. Among them, the probiotics market is growing rapidly, with the dedicated research and development of Fenghua Biotechnology Company leading the way. Recently, Fenghua invested hundreds of millions of dollars to expand its factories in Chiayi and Tainan, and the Chiayi factory was completed in the first quarter of this year. The annual production capacity of probiotics has increased eightfold, while the Tainan factory, located in the Xinyi Science Park, is expected to be completed by the end of September this year. After the completion of both plants, they will play a leading role in Fenghua's top-notch technology and R&D; achievements, bringing strong support and operational growth momentum.

The gut is the body's largest immune organ, and the balance of gut bacteria is a crucial factor in determining gut health. To meet the needs of people's health and help adjust the intestinal environment and digestive absorption, Fenghua Biotechnology has launched the complex "10 probiotics" raw materials, which have been selected by global direct sales, distribution channels, and pharmacist brands for a long time.

Fenghua Biotechnology General Manager Huang Sheng-hung said that Fenghua Biotechnology has long been focused on probiotics research. With the efforts of several doctors and R&D; colleagues, it has built a "probiotic strain library" of thousands of strains and a "functional probiotic screening and verification platform." Starting from probiotic raw materials, Fenghua has continued to refine its R&D;, currently holding over 100 global patents, using exclusive PRONEX technology to ensure raw material quality, and possessing multiple clinical trial verifications. It provides customers around the world with one-stop service from customized formulas to end-product production - PRIMETEK.

Probiotics and postbiotics are important raw materials in the health market, and the PRONULIFE functional probiotic series and postbiotic Totipro products with human clinical evidence have opened up a new chapter in probiotic use.

Postbiotic raw materials have become a trend in global health food ingredients in recent years. Fenghua Biotechnology carefully selects functional strains and ferments them to produce small molecule nutrients. After treatment with heat-locking technology, it retains its nutritional essence and is called "Yicui quality." It has functions such as helping good bacteria growth, aiding digestion, promoting bowel movements, and regulating immunity.

Currently, Totipro Yicui quality raw materials have been used in various dietary supplements, and studies have shown significant benefits for gut and oral health, greatly increasing the value of the product. As a leading enterprise in probiotics, Fenghua will continue to invest in probiotic research and expand its production capacity, providing the highest quality probiotic food products for customers around the world and for the people of Taiwan. Fenghua Biotechnology's official website: glac.com.tw.
 
相關文章
豐華生物科技股份有限公司
電話 : +886-6-589-1876 連絡人: 林榮錦 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.) 信箱 : glac@glac.com.tw

  • 服務項目

  • 特別關鍵字